1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of Market Research Methodology 15
1.2.2 Market Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 28
2.1.3 Impact of Russia-Ukraine Conflict 30
2.1.4 Impact of Israel-Palestine War 32
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 42
2.4 Emerging Opportunities and Market Trends 45
2.5 Porter?s Fiver Forces Analysis 49
3 Segmentation of Global Market by Product Type 53
3.1 Market Overview by Product Type 53
3.2 Monoclonal Antibodies 55
3.2.1 Anti-cancer Monoclonal Antibodies 56
3.2.2 Anti-inflammatory Monoclonal Antibodies 57
3.2.3 Other Monoclonal Antibodies 58
3.3 Recombinant Growth Factors 59
3.3.1 Erythropoietin 60
3.3.2 Granulocyte Colony Stimulating Factor 61
3.4 Purified Proteins 62
3.4.1 Leukemia Inhibitory Factor (LIF) 63
3.4.2 P53 Protein 64
3.4.3 P38 Protein 65
3.4.4 Other Purified Proteins 66
3.5 Recombinant Proteins 67
3.5.1 Serum Albumin 68
3.5.2 Amyloid Protein 69
3.5.3 Defensin 70
3.5.4 Transferrin 71
3.6 Recombinant Hormones 72
3.6.1 Recombinant Human Growth Hormones 73
3.6.2 Recombinant Insulin 75
3.6.3 Other Recombinant Hormones 76
3.7 Vaccines 77
3.7.1 Recombinant Vaccines 78
3.7.2 Conventional Vaccines 80
3.8 Recombinant Enzymes 81
3.8.1 Enterokinase 82
3.8.2 Cyclase 83
3.8.3 Caspase 84
3.8.4 Cathepsin 85
3.9 Cell and Gene Therapies 86
3.9.1 Allogenic Products 87
3.9.2 Autologous Products 88
3.9.3 Acellular Products 89
3.10 Synthetic Immunomodulators 90
3.11 Other Product Types 91
3.11.1 Blood Factors 92
3.11.2 Other Products 93
4 Segmentation of Global Market by Testing Service 94
4.1 Market Overview by Testing Service 94
4.2 Laboratory Testing 96
4.3 Custom Testing/Customer Proprietary Testing 97
4.4 Compendial and Multi Compendial Laboratory Testing 98
5 Segmentation of Global Market by Raw Material 99
5.1 Market Overview by Raw Material 99
5.2 Formulation Excipients 101
5.3 Active Pharmaceutical Ingredients (API) 102
5.4 Other Materials 103
6 Segmentation of Global Market by Classification 104
6.1 Market Overview by Classification 104
6.2 Innovative Biopharmaceuticals 106
6.3 Biogenerics and Biosimilars 107
7 Segmentation of Global Market by Therapeutic Area 108
7.1 Market Overview by Therapeutic Area 108
7.2 Oncology 110
7.3 Inflammatory and Infectious Diseases 111
7.4 Autoimmune Disorders 112
7.5 Metabolic Disorders 113
7.6 Hormonal Disorders 114
7.7 Cardiovascular Diseases 115
7.8 Neurological Diseases 116
7.9 Other Therapeutic Areas 117
8 Segmentation of Global Market by Region 118
8.1 Geographic Market Overview 2023-2033 118
8.2 North America Market 2023-2033 by Country 122
8.2.1 Overview of North America Market 122
8.2.2 U.S. 126
8.2.3 Canada 129
8.2.4 Mexico 131
8.3 European Market 2023-2033 by Country 133
8.3.1 Overview of European Market 133
8.3.2 Germany 137
8.3.3 U.K. 139
8.3.4 France 141
8.3.5 Spain 143
8.3.6 Italy 145
8.3.7 Netherlands 147
8.3.8 Rest of European Market 149
8.4 Asia-Pacific Market 2023-2033 by Country 151
8.4.1 Overview of Asia-Pacific Market 151
8.4.2 Japan 155
8.4.3 China 158
8.4.4 Australia 160
8.4.5 India 162
8.4.6 South Korea 164
8.4.7 Rest of APAC Region 166
8.5 South America Market 2023-2033 by Country 168
8.5.1 Argentina 171
8.5.2 Brazil 173
8.5.3 Chile 175
8.5.4 Rest of South America Market 177
8.6 MEA Market 2023-2033 by Country 178
8.6.1 UAE 181
8.6.2 Saudi Arabia 183
8.6.3 South Africa 185
8.6.4 Other National Markets 187
9 Competitive Landscape 188
9.1 Overview of Key Vendors 188
9.2 New Product Launch, Partnership, Investment, and M&A 192
9.3 Company Profiles 193
Abbott Laboratories 193
Amgen Inc. 195
Astrazeneca PLC 196
Bayer AG 197
Biogen Inc. 198
Bristol-myers Squibb Company (BMS) 199
Eli Lilly and Company 200
F. Hoffmann-La Roche Ltd. 201
Glaxosmithkline PLC 202
Johnson & Johnson 203
Merck & Co. Inc. 204
Novartis Ag 205
Novo Nordisk As 206
Pfizer Inc. 207
Sanofi Sa 208
Sharp Packaging Services 209
Sun Pharmaceutical Industries Ltd. 210
Takeda Pharmaceutical Company Limited 211
Thermo Fisher Scientific Inc. 212
Vertex Pharmaceuticals 213
WuXi AppTec 214
RELATED REPORTS 215